Warning: Undefined variable $count in /home/seniorca/public_html/wp-content/themes/divi-news-child-healthcare/index.php on line 40

Warning: Undefined variable $count in /home/seniorca/public_html/wp-content/themes/divi-news-child-healthcare/index.php on line 121
Health Care M&A Weekly Deals, The Week Ending April 6, 2018

Health Care M&A Weekly Deals, The Week Ending April 6, 2018

We hope you are enjoying your membership to HealthCareMandA.com. This Health Care M&A Weekly chart below is a selection of transactions announced during the prior week(s). The deals presented here are further elaborated in the monthly newsletter, Health Care M&A News, and in the quarterly report. This information also appears in our online database, Deal Search Online. Visit www.dealsearchonline.com to open a guest account and begin your search. Biotechnology Acquirer Target Price Agilent Technologies Inc. Lasergen, Inc. $105 million MedImmune Exclusive license to antibody products $10 million Ferring Pharmaceuticals Rebiotix Inc. N/A UCB S.A. Element Genomics $30 million Novo... Read More »
Q1:18 Results: Healthcare Goes Retail

Q1:18 Results: Healthcare Goes Retail

First, the easy news. Deal volume in the first quarter of 2018 was on par with the previous quarter’s total of 380 deals. Preliminary data show 378 transactions were announced in the first quarter, making for a decline of 1% that will likely be erased as more deal activity is uncovered. Compared with the first quarter in 2017, however, deal volume was down 14%, versus the 439 deals reported then. Deal value for the quarter is where the data deviates from previous norms. The first quarter in 2017 posted a very robust $59.6 billion in disclosed deal value. In the fourth quarter of the year, deal value leapt to nearly $115.0 billion, thanks largely to the $77 billion proposed acquisition of... Read More »
Health Care M&A Weekly Deals, The Week Ending April 6, 2018

Health Care M&A Weekly Deals, The Week Ending March 30, 2018

We hope you are enjoying your membership to HealthCareMandA.com. This Health Care M&A Weekly chart below is a selection of transactions announced during the prior week(s). The deals presented here are further elaborated in the monthly newsletter, Health Care M&A News, and in the quarterly report. This information also appears in our online database, Deal Search Online. Visit www.dealsearchonline.com to open a guest account and begin your search. Biotechnology Acquirer Target Price Celgene Corporation Exclusive worldwide license to ABX-1772 N/A BioIVT Ascendance Biotechnology, Inc. N/A Roivant Sciences Exclusive license to lefamulin $5 million Hospitals Acquirer Target Price IK... Read More »
Health Care M&A Weekly Deals, The Week Ending April 6, 2018

Health Care M&A Weekly Deals, The Week Ending March 23, 2018

We hope you are enjoying your membership to HealthCareMandA.com. This Health Care M&A Weekly chart below is a selection of transactions announced during the prior week(s). The deals presented here are further elaborated in the monthly newsletter, Health Care M&A News, and in the quarterly report. This information also appears in our online database, Deal Search Online. Visit www.dealsearchonline.com to open a guest account and begin your search. Behavioral Health Care Acquirer Target Price Netcare Limited Akeso Clinics $108 million Biotechnology Acquirer Target Price UCB S.A. Exclusive license to inflammatory drug candidate N/A SYGNIS AG TGR Biosciences $7.98 million Knight... Read More »
Health Care M&A Weekly Deals, The Week Ending April 6, 2018

Health Care M&A Weekly Deals, The Week Ending March 16, 2018

We hope you are enjoying your membership to HealthCareMandA.com. This Health Care M&A Weekly chart below is a selection of transactions announced during the prior week(s). The deals presented here are further elaborated in the monthly newsletter, Health Care M&A News, and in the quarterly report. This information also appears in our online database, Deal Search Online. Visit www.dealsearchonline.com to open a guest account and begin your search. Biotechnology Acquirer Target Price H. Lundbeck A/S Prexton Therapeutics B.V. $123 million ImmunoRestoration, Inc. Exclusive license to cancer vaccine platform N/A eHealth Acquirer Target Price Cognizant Technology Solutions Corp. Bolder... Read More »
Health Care M&A Weekly Deals, The Week Ending April 6, 2018

Health Care M&A Weekly Deals, The Week Ending March 9, 2018

We hope you are enjoying your membership to HealthCareMandA.com. This Health Care M&A Weekly chart below is a selection of transactions announced during the prior week(s). The deals presented here are further elaborated in the monthly newsletter, Health Care M&A News, and in the quarterly report. This information also appears in our online database, Deal Search Online. Visit www.dealsearchonline.com to open a guest account and begin your search. Behavioral Health Care Acquirer Target Price BayMark Health Services Canadian Addiction Treatment Centers N/A       Biotechnology Acquirer Target Price Roivant Sciences License to LGD-6972 N/A OHM Oncology Exclusive license to dual... Read More »